Concepts (305)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Astrocytes | 12 | 2022 | 255 | 2.940 |
Why?
|
| Potassium Channels, Inwardly Rectifying | 13 | 2020 | 61 | 2.870 |
Why?
|
| Polyamines | 5 | 2023 | 30 | 1.310 |
Why?
|
| Neuroglia | 10 | 2024 | 124 | 1.280 |
Why?
|
| Glucose | 2 | 2020 | 230 | 1.100 |
Why?
|
| Spermine | 8 | 2023 | 64 | 1.090 |
Why?
|
| Neurons | 21 | 2023 | 1175 | 0.970 |
Why?
|
| Rats | 39 | 2024 | 3483 | 0.910 |
Why?
|
| Potassium Channels | 8 | 2010 | 75 | 0.890 |
Why?
|
| Potassium | 8 | 2015 | 112 | 0.860 |
Why?
|
| Gene Expression Regulation | 3 | 2020 | 1015 | 0.850 |
Why?
|
| Retina | 8 | 2024 | 280 | 0.840 |
Why?
|
| Glutamic Acid | 2 | 2015 | 128 | 0.830 |
Why?
|
| Potassium Channels, Tandem Pore Domain | 3 | 2015 | 14 | 0.790 |
Why?
|
| Hyperglycemia | 1 | 2020 | 55 | 0.680 |
Why?
|
| Animals | 53 | 2024 | 15081 | 0.660 |
Why?
|
| Up-Regulation | 3 | 2018 | 513 | 0.650 |
Why?
|
| A Kinase Anchor Proteins | 1 | 2018 | 8 | 0.640 |
Why?
|
| Membrane Potentials | 13 | 2015 | 223 | 0.560 |
Why?
|
| Brain Ischemia | 1 | 2018 | 184 | 0.540 |
Why?
|
| Sweetening Agents | 1 | 2015 | 12 | 0.530 |
Why?
|
| Mutation, Missense | 1 | 2016 | 83 | 0.520 |
Why?
|
| Ischemic Attack, Transient | 1 | 2015 | 20 | 0.520 |
Why?
|
| Dopamine | 12 | 2014 | 245 | 0.510 |
Why?
|
| Brain Diseases | 1 | 2014 | 32 | 0.500 |
Why?
|
| Stroke | 1 | 2018 | 286 | 0.490 |
Why?
|
| MicroRNAs | 1 | 2020 | 426 | 0.490 |
Why?
|
| Cell Membrane | 7 | 2015 | 381 | 0.490 |
Why?
|
| Protein Biosynthesis | 1 | 2015 | 133 | 0.490 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2016 | 767 | 0.470 |
Why?
|
| Cells, Cultured | 10 | 2020 | 1518 | 0.450 |
Why?
|
| Seizures | 3 | 2022 | 68 | 0.440 |
Why?
|
| Brain | 7 | 2023 | 1346 | 0.430 |
Why?
|
| Receptors, Dopamine D2 | 6 | 1998 | 73 | 0.430 |
Why?
|
| Quinolines | 5 | 2010 | 64 | 0.430 |
Why?
|
| Prolactin | 6 | 1998 | 62 | 0.430 |
Why?
|
| Patch-Clamp Techniques | 7 | 2015 | 223 | 0.360 |
Why?
|
| Dopamine Agents | 4 | 1998 | 25 | 0.350 |
Why?
|
| Receptors, Nicotinic | 3 | 2006 | 106 | 0.350 |
Why?
|
| Stress, Psychological | 1 | 2014 | 583 | 0.320 |
Why?
|
| Spermidine | 5 | 2024 | 33 | 0.320 |
Why?
|
| Diencephalon | 3 | 1994 | 7 | 0.300 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 2 | 1996 | 25 | 0.290 |
Why?
|
| Norepinephrine | 3 | 1996 | 110 | 0.280 |
Why?
|
| Receptors, sigma | 2 | 1996 | 15 | 0.280 |
Why?
|
| Pituitary Gland | 3 | 1996 | 63 | 0.280 |
Why?
|
| Salicylamides | 4 | 1993 | 13 | 0.280 |
Why?
|
| Rats, Sprague-Dawley | 6 | 2020 | 1618 | 0.270 |
Why?
|
| Acetylcholine | 3 | 2006 | 73 | 0.270 |
Why?
|
| Carbazoles | 2 | 1996 | 42 | 0.270 |
Why?
|
| Ion Channel Gating | 5 | 2014 | 83 | 0.270 |
Why?
|
| Antipsychotic Agents | 2 | 1996 | 68 | 0.270 |
Why?
|
| Putrescine | 2 | 2022 | 25 | 0.270 |
Why?
|
| Dose-Response Relationship, Drug | 8 | 2015 | 1039 | 0.260 |
Why?
|
| Nicotinic Agonists | 2 | 2006 | 75 | 0.250 |
Why?
|
| Spermidine Synthase | 1 | 2024 | 2 | 0.240 |
Why?
|
| Hypothalamus | 6 | 1998 | 129 | 0.240 |
Why?
|
| Nicotinic Antagonists | 1 | 2004 | 30 | 0.240 |
Why?
|
| Diterpenes | 1 | 2004 | 92 | 0.230 |
Why?
|
| Glioma | 2 | 2015 | 79 | 0.220 |
Why?
|
| Amino Acid Substitution | 2 | 2016 | 132 | 0.220 |
Why?
|
| Connexin 43 | 2 | 2021 | 38 | 0.220 |
Why?
|
| alpha-MSH | 2 | 1993 | 4 | 0.220 |
Why?
|
| Remoxipride | 2 | 1992 | 2 | 0.220 |
Why?
|
| Brain Neoplasms | 2 | 2015 | 111 | 0.220 |
Why?
|
| Nicotine | 2 | 2006 | 257 | 0.210 |
Why?
|
| Receptors, Drug | 2 | 2002 | 58 | 0.210 |
Why?
|
| ATP-Binding Cassette Transporters | 2 | 2002 | 83 | 0.210 |
Why?
|
| Rana pipiens | 6 | 2008 | 62 | 0.200 |
Why?
|
| Electroencephalography | 1 | 2022 | 116 | 0.200 |
Why?
|
| 3,4-Dihydroxyphenylacetic Acid | 10 | 1998 | 27 | 0.190 |
Why?
|
| Biological Transport | 1 | 2021 | 185 | 0.190 |
Why?
|
| Animals, Newborn | 3 | 2024 | 343 | 0.190 |
Why?
|
| Receptors, Dopamine | 2 | 1996 | 25 | 0.180 |
Why?
|
| Analysis of Variance | 3 | 2015 | 550 | 0.170 |
Why?
|
| Male | 22 | 2018 | 20025 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 5 | 2021 | 1609 | 0.150 |
Why?
|
| Amygdala | 2 | 1996 | 114 | 0.150 |
Why?
|
| Immunohistochemistry | 7 | 2004 | 893 | 0.150 |
Why?
|
| Ouabain | 3 | 2013 | 15 | 0.150 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 1996 | 48 | 0.140 |
Why?
|
| Corticosterone | 1 | 1996 | 77 | 0.140 |
Why?
|
| Mice | 9 | 2021 | 5913 | 0.140 |
Why?
|
| Melanocyte-Stimulating Hormones | 1 | 1996 | 7 | 0.140 |
Why?
|
| Median Eminence | 3 | 1998 | 10 | 0.140 |
Why?
|
| Neocortex | 1 | 2015 | 27 | 0.130 |
Why?
|
| Corpus Striatum | 2 | 1993 | 104 | 0.130 |
Why?
|
| Rats, Inbred Strains | 7 | 1996 | 133 | 0.130 |
Why?
|
| Focal Adhesion Kinase 2 | 1 | 2015 | 14 | 0.130 |
Why?
|
| Colorimetry | 1 | 2015 | 40 | 0.130 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2015 | 70 | 0.130 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 2 | 2006 | 28 | 0.130 |
Why?
|
| Quinine | 1 | 2014 | 10 | 0.130 |
Why?
|
| Time Factors | 3 | 2015 | 1742 | 0.130 |
Why?
|
| Thalamus | 1 | 1994 | 30 | 0.120 |
Why?
|
| Frontal Lobe | 1 | 1994 | 48 | 0.120 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2015 | 77 | 0.120 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2014 | 32 | 0.120 |
Why?
|
| Staining and Labeling | 2 | 2012 | 105 | 0.120 |
Why?
|
| Synaptic Transmission | 1 | 1994 | 146 | 0.120 |
Why?
|
| Cerebral Cortex | 2 | 2013 | 290 | 0.110 |
Why?
|
| Microglia | 1 | 2015 | 166 | 0.110 |
Why?
|
| Kainic Acid | 1 | 2013 | 48 | 0.110 |
Why?
|
| Oocytes | 4 | 2011 | 146 | 0.110 |
Why?
|
| Raclopride | 4 | 1993 | 8 | 0.110 |
Why?
|
| Receptors, AMPA | 1 | 2013 | 56 | 0.110 |
Why?
|
| RNA, Messenger | 3 | 2015 | 1207 | 0.110 |
Why?
|
| Pyridinium Compounds | 1 | 2012 | 27 | 0.110 |
Why?
|
| Behavior, Animal | 1 | 2014 | 314 | 0.110 |
Why?
|
| Cell Line, Tumor | 2 | 2016 | 2231 | 0.100 |
Why?
|
| Xenopus laevis | 3 | 2011 | 73 | 0.100 |
Why?
|
| Cocaine | 1 | 2014 | 232 | 0.100 |
Why?
|
| Cell Communication | 1 | 2012 | 97 | 0.100 |
Why?
|
| Down-Regulation | 1 | 2013 | 435 | 0.100 |
Why?
|
| Large-Conductance Calcium-Activated Potassium Channels | 1 | 2011 | 22 | 0.100 |
Why?
|
| Central Nervous System | 2 | 2022 | 135 | 0.090 |
Why?
|
| Channelopathies | 1 | 2010 | 5 | 0.090 |
Why?
|
| Barium | 1 | 2010 | 17 | 0.090 |
Why?
|
| Mice, Inbred DBA | 1 | 2010 | 71 | 0.090 |
Why?
|
| Abnormalities, Multiple | 1 | 2010 | 36 | 0.090 |
Why?
|
| Organic Cation Transport Proteins | 1 | 2010 | 12 | 0.090 |
Why?
|
| Rats, Wistar | 5 | 2013 | 233 | 0.090 |
Why?
|
| Radioimmunoassay | 3 | 1996 | 65 | 0.090 |
Why?
|
| Ventromedial Hypothalamic Nucleus | 1 | 1990 | 6 | 0.090 |
Why?
|
| Calcium | 1 | 2013 | 480 | 0.090 |
Why?
|
| Hippocampus | 2 | 2010 | 561 | 0.090 |
Why?
|
| Humans | 8 | 2015 | 37093 | 0.090 |
Why?
|
| Electric Stimulation | 4 | 2002 | 184 | 0.090 |
Why?
|
| Neuropeptides | 1 | 1989 | 59 | 0.090 |
Why?
|
| Amino Acids | 1 | 1990 | 145 | 0.080 |
Why?
|
| Giant Cells | 2 | 2022 | 13 | 0.080 |
Why?
|
| Huntington Disease | 1 | 2008 | 27 | 0.080 |
Why?
|
| Gap Junctions | 2 | 2022 | 38 | 0.080 |
Why?
|
| Mutation | 2 | 2010 | 1095 | 0.080 |
Why?
|
| DNA, Mitochondrial | 1 | 2008 | 175 | 0.080 |
Why?
|
| HIV Infections | 1 | 2021 | 2303 | 0.070 |
Why?
|
| Nerve Tissue Proteins | 2 | 2014 | 360 | 0.070 |
Why?
|
| Methoxyhydroxyphenylglycol | 3 | 1996 | 15 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2010 | 628 | 0.070 |
Why?
|
| Disease Models, Animal | 3 | 2022 | 1371 | 0.070 |
Why?
|
| DNA Damage | 1 | 2008 | 352 | 0.070 |
Why?
|
| Female | 12 | 2013 | 20969 | 0.070 |
Why?
|
| Muscle, Skeletal | 2 | 2006 | 282 | 0.060 |
Why?
|
| Tissue Distribution | 2 | 2002 | 207 | 0.060 |
Why?
|
| Serotonin | 3 | 1996 | 123 | 0.060 |
Why?
|
| Stereoisomerism | 1 | 2004 | 167 | 0.060 |
Why?
|
| Adenosine Triphosphate | 2 | 2002 | 196 | 0.060 |
Why?
|
| Limbic System | 2 | 1995 | 25 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2010 | 364 | 0.050 |
Why?
|
| Fluorescent Dyes | 2 | 2014 | 181 | 0.050 |
Why?
|
| Ranidae | 1 | 2002 | 12 | 0.050 |
Why?
|
| Anticonvulsants | 1 | 2022 | 34 | 0.050 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2022 | 79 | 0.050 |
Why?
|
| Acids | 1 | 2002 | 18 | 0.050 |
Why?
|
| Extracellular Space | 1 | 2002 | 35 | 0.050 |
Why?
|
| Ion Channels | 1 | 2002 | 71 | 0.050 |
Why?
|
| Larva | 1 | 2002 | 124 | 0.050 |
Why?
|
| Transfection | 3 | 2010 | 523 | 0.050 |
Why?
|
| Protons | 1 | 2002 | 84 | 0.050 |
Why?
|
| Biogenic Monoamines | 2 | 1992 | 31 | 0.050 |
Why?
|
| Protein Structure, Tertiary | 2 | 2014 | 408 | 0.050 |
Why?
|
| In Situ Hybridization | 2 | 2001 | 129 | 0.050 |
Why?
|
| Vision, Ocular | 1 | 2001 | 41 | 0.050 |
Why?
|
| Eflornithine | 1 | 2020 | 18 | 0.050 |
Why?
|
| Energy Metabolism | 1 | 2001 | 168 | 0.050 |
Why?
|
| Mice, Transgenic | 2 | 2015 | 617 | 0.050 |
Why?
|
| Aspartic Acid | 2 | 1990 | 47 | 0.040 |
Why?
|
| Action Potentials | 3 | 1990 | 231 | 0.040 |
Why?
|
| Protein Transport | 1 | 2020 | 302 | 0.040 |
Why?
|
| Aging | 1 | 2024 | 664 | 0.040 |
Why?
|
| Receptors, Dopamine D1 | 1 | 1998 | 40 | 0.040 |
Why?
|
| Enzyme Inhibitors | 2 | 2013 | 433 | 0.040 |
Why?
|
| Apomorphine | 2 | 1996 | 13 | 0.040 |
Why?
|
| Benzopyrans | 1 | 1997 | 14 | 0.040 |
Why?
|
| Oxazines | 1 | 1997 | 26 | 0.040 |
Why?
|
| Dopamine Agonists | 1 | 1997 | 30 | 0.040 |
Why?
|
| Benzimidazoles | 1 | 1997 | 36 | 0.040 |
Why?
|
| Pentazocine | 1 | 1996 | 3 | 0.040 |
Why?
|
| Dopamine Antagonists | 1 | 1996 | 44 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 1996 | 82 | 0.030 |
Why?
|
| Sulfonamides | 1 | 1996 | 80 | 0.030 |
Why?
|
| Amino Acid Sequence | 2 | 2010 | 1180 | 0.030 |
Why?
|
| Piperazines | 1 | 1996 | 111 | 0.030 |
Why?
|
| Signal Transduction | 2 | 2015 | 1908 | 0.030 |
Why?
|
| Molecular Sequence Data | 2 | 2010 | 1568 | 0.030 |
Why?
|
| HIV-1 | 1 | 2021 | 706 | 0.030 |
Why?
|
| Reticular Formation | 1 | 1995 | 4 | 0.030 |
Why?
|
| Torpedo | 2 | 2006 | 41 | 0.030 |
Why?
|
| Neurochemistry | 1 | 1994 | 6 | 0.030 |
Why?
|
| COS Cells | 2 | 2007 | 69 | 0.030 |
Why?
|
| Kinetics | 1 | 1996 | 708 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 1996 | 562 | 0.030 |
Why?
|
| Dopamine Plasma Membrane Transport Proteins | 1 | 2014 | 50 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2020 | 1198 | 0.030 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2006 | 64 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2015 | 173 | 0.030 |
Why?
|
| Electrophysiology | 2 | 2008 | 136 | 0.030 |
Why?
|
| Alligators and Crocodiles | 1 | 2014 | 9 | 0.030 |
Why?
|
| Glutamates | 1 | 2014 | 22 | 0.030 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 1994 | 78 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 251 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2014 | 177 | 0.030 |
Why?
|
| Rats, Long-Evans | 2 | 2008 | 89 | 0.030 |
Why?
|
| Locomotion | 1 | 2014 | 97 | 0.030 |
Why?
|
| Immune Sera | 1 | 1993 | 59 | 0.030 |
Why?
|
| Adamantane | 1 | 2013 | 8 | 0.030 |
Why?
|
| Sex Factors | 2 | 1993 | 898 | 0.030 |
Why?
|
| Intracellular Fluid | 1 | 2012 | 26 | 0.030 |
Why?
|
| Carbenoxolone | 1 | 2012 | 10 | 0.030 |
Why?
|
| Piperidines | 1 | 2013 | 77 | 0.030 |
Why?
|
| Brain Chemistry | 1 | 1993 | 140 | 0.030 |
Why?
|
| CA1 Region, Hippocampal | 1 | 2012 | 34 | 0.030 |
Why?
|
| Nerve Degeneration | 1 | 2013 | 107 | 0.030 |
Why?
|
| Cation Transport Proteins | 1 | 2012 | 34 | 0.030 |
Why?
|
| Isoquinolines | 1 | 2012 | 45 | 0.030 |
Why?
|
| Substantia Nigra | 1 | 1992 | 44 | 0.030 |
Why?
|
| Receptors, Opioid | 1 | 1992 | 51 | 0.030 |
Why?
|
| Calcium Signaling | 1 | 2013 | 101 | 0.030 |
Why?
|
| Morphine | 1 | 1992 | 85 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2012 | 218 | 0.030 |
Why?
|
| Recombinant Proteins | 2 | 2008 | 515 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 2012 | 252 | 0.030 |
Why?
|
| Cell Movement | 1 | 2015 | 571 | 0.030 |
Why?
|
| Antibody Specificity | 2 | 2001 | 79 | 0.020 |
Why?
|
| Cricetulus | 1 | 2011 | 80 | 0.020 |
Why?
|
| CHO Cells | 1 | 2011 | 124 | 0.020 |
Why?
|
| Ataxia | 1 | 2010 | 9 | 0.020 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2010 | 8 | 0.020 |
Why?
|
| Cricetinae | 1 | 2011 | 238 | 0.020 |
Why?
|
| Syndrome | 1 | 2010 | 74 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 1992 | 421 | 0.020 |
Why?
|
| Kynurenic Acid | 1 | 1990 | 9 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2010 | 269 | 0.020 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 1990 | 33 | 0.020 |
Why?
|
| Fluorescence | 1 | 2010 | 121 | 0.020 |
Why?
|
| Substance P | 1 | 1989 | 26 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2010 | 103 | 0.020 |
Why?
|
| Homeostasis | 1 | 2011 | 188 | 0.020 |
Why?
|
| Neurotransmitter Agents | 1 | 1989 | 63 | 0.020 |
Why?
|
| Propionates | 1 | 2008 | 26 | 0.020 |
Why?
|
| Guanosine | 1 | 2008 | 27 | 0.020 |
Why?
|
| Nitro Compounds | 1 | 2008 | 33 | 0.020 |
Why?
|
| Pregnancy | 1 | 2013 | 1549 | 0.020 |
Why?
|
| Amino Acid Motifs | 1 | 2007 | 91 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 2007 | 52 | 0.020 |
Why?
|
| Tyrosine | 1 | 2007 | 118 | 0.020 |
Why?
|
| Models, Molecular | 1 | 2010 | 808 | 0.020 |
Why?
|
| Cell Nucleus | 1 | 2008 | 366 | 0.020 |
Why?
|
| Cell Line | 1 | 2010 | 1354 | 0.020 |
Why?
|
| Dansyl Compounds | 1 | 2006 | 7 | 0.020 |
Why?
|
| Erythrocyte Membrane | 1 | 2006 | 20 | 0.020 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2006 | 34 | 0.020 |
Why?
|
| Sheep | 1 | 2006 | 72 | 0.020 |
Why?
|
| Spectrometry, Fluorescence | 1 | 2006 | 208 | 0.020 |
Why?
|
| Cholinergic Agents | 1 | 2004 | 8 | 0.010 |
Why?
|
| Electric Organ | 1 | 2004 | 18 | 0.010 |
Why?
|
| Membranes | 1 | 2004 | 19 | 0.010 |
Why?
|
| Diaphragm | 1 | 2004 | 11 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2007 | 928 | 0.010 |
Why?
|
| Xenopus | 1 | 2004 | 48 | 0.010 |
Why?
|
| Dihydroxyphenylalanine | 2 | 1993 | 8 | 0.010 |
Why?
|
| Tolbutamide | 1 | 2002 | 5 | 0.010 |
Why?
|
| Ligands | 1 | 2004 | 349 | 0.010 |
Why?
|
| Rana catesbeiana | 1 | 2002 | 30 | 0.010 |
Why?
|
| Vasodilator Agents | 1 | 2002 | 56 | 0.010 |
Why?
|
| Third Ventricle | 1 | 2001 | 3 | 0.010 |
Why?
|
| Purkinje Cells | 1 | 2002 | 20 | 0.010 |
Why?
|
| Dendrites | 1 | 2001 | 55 | 0.010 |
Why?
|
| Pyramidal Cells | 1 | 2002 | 63 | 0.010 |
Why?
|
| G Protein-Coupled Inwardly-Rectifying Potassium Channels | 1 | 2001 | 5 | 0.010 |
Why?
|
| Interneurons | 1 | 2002 | 56 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 2001 | 209 | 0.010 |
Why?
|
| Motor Neurons | 1 | 2002 | 83 | 0.010 |
Why?
|
| Electric Conductivity | 1 | 2000 | 51 | 0.010 |
Why?
|
| Hypoglycemic Agents | 1 | 2002 | 160 | 0.010 |
Why?
|
| Synapses | 1 | 2001 | 180 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2002 | 286 | 0.010 |
Why?
|
| 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine | 1 | 1998 | 9 | 0.010 |
Why?
|
| Receptors, Dopamine D3 | 1 | 1997 | 12 | 0.010 |
Why?
|
| Amphetamines | 1 | 1996 | 5 | 0.010 |
Why?
|
| Genes, fos | 1 | 1996 | 14 | 0.010 |
Why?
|
| Nucleus Accumbens | 1 | 1997 | 82 | 0.010 |
Why?
|
| Receptors, Dopamine D4 | 1 | 1996 | 14 | 0.010 |
Why?
|
| Biological Availability | 1 | 1996 | 88 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 1996 | 325 | 0.010 |
Why?
|
| Phytohemagglutinins | 1 | 1995 | 13 | 0.010 |
Why?
|
| Efferent Pathways | 1 | 1995 | 14 | 0.010 |
Why?
|
| Binding Sites | 1 | 1996 | 651 | 0.010 |
Why?
|
| Motor Activity | 1 | 1996 | 418 | 0.010 |
Why?
|
| Dorsomedial Hypothalamic Nucleus | 1 | 1993 | 4 | 0.010 |
Why?
|
| 8-Hydroxy-2-(di-n-propylamino)tetralin | 1 | 1993 | 6 | 0.010 |
Why?
|
| 5-Hydroxytryptophan | 1 | 1993 | 4 | 0.010 |
Why?
|
| Thalamic Nuclei | 1 | 1993 | 8 | 0.010 |
Why?
|
| Catecholamines | 1 | 1993 | 44 | 0.010 |
Why?
|
| Hydrolysis | 1 | 1993 | 99 | 0.010 |
Why?
|
| 5,6-Dihydroxytryptamine | 1 | 1992 | 2 | 0.010 |
Why?
|
| Hypothalamus, Middle | 1 | 1992 | 4 | 0.010 |
Why?
|
| Catheterization | 1 | 1992 | 24 | 0.010 |
Why?
|
| Receptors, Opioid, kappa | 1 | 1992 | 22 | 0.010 |
Why?
|
| Injections, Intraventricular | 1 | 1992 | 64 | 0.010 |
Why?
|
| Creatinine | 1 | 1992 | 103 | 0.010 |
Why?
|
| Receptors, Opioid, mu | 1 | 1992 | 55 | 0.010 |
Why?
|
| Gonads | 1 | 1992 | 20 | 0.010 |
Why?
|
| Castration | 1 | 1992 | 34 | 0.010 |
Why?
|
| Steroids | 1 | 1992 | 43 | 0.010 |
Why?
|